Showing results (851-860 of 6,768) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|October 4, 2024
Population Pharmacokinetic Model of Intravenous Immunoglobulin in Patients Treated for Various Immune System DisordersJian Lynn Lee, Noraida Mohamed Shah, Mohd Makmor-Bakry, et al.
Clinical Therapeutics|October 5, 2024
Dosing of Venetoclax in Pediatric Patients with Relapsed Acute Myeloid Leukemia: Analysis of Developmental Pharmacokinetics and Exposure-Response RelationshipsMohamed Badawi, Sathej Gopalakrishnan, Benjamin Engelhardt, et al.
Clinical Therapeutics|October 20, 2024
Unraveling the Spectrum of Ocular Toxicity with Oxaliplatin: Clinical Feature Analysis of Cases and Pharmacovigilance Assessment of the US Food and Drug Administration Adverse Event Reporting System DatabaseWensheng Liu, Xuan Ye, Han Shan, et al.
Clinical Therapeutics|October 22, 2024
Cost-effectiveness Analysis of Tumor Treating Fields Therapy Combined With Immune Checkpoint Inhibitor in Metastatic Non-small-cell Lung CancerMengwei Zhang, Ping Yue, Yuanying Feng, et al.
Clinical Therapeutics|October 1, 2024
A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19Harish Seethamraju, Otto O Yang, Richard Loftus, et al.
Clinical Therapeutics|September 17, 2024
Cost-Effectiveness of Zanubrutinib Versus Bendamustine and Rituximab in Patients With Untreated Chronic Lymphocytic LeukemiaJing Nie, Lihui Liu, Huina Wu, et al.
Clinical Therapeutics|September 20, 2024
Oncology Dose Selection in Subsequent Indications: What Can We Learn From FDA-approved Oncology Drugs?Huy X Ngo, Elise Oh, Chunze Li, et al.
Clinical Therapeutics|November 8, 2024
Correlation Between Vitamin D, Inflammatory Markers, and T Lymphocytes With the Severity of Chronic Obstructive Pulmonary Disease and its Effect on the Risk of Acute Exacerbation: A Single Cross-sectional StudyYeqian Jiang, Mingzhu Li, Yan Yu, et al.
Clinical Therapeutics|March 2, 2025
Febuxostat, a Urate-Lowering Drug Bridging From Adults to Pediatrics; A Brief ReportToktam Faghihi, Farahnak Assadi
Clinical Therapeutics|August 1, 2024
Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's DiseaseNayoung Kwak, Myung-Jun Lee, Hye-Young Kang, et al.
Pageof 677